1. Introduction {#s0005}
===============

Approximately one-third of the 700,000 troops deployed to the 1991 Persian Gulf War developed chronic physical and psychological symptoms known as Gulf War Illness (GWI). To date, it is the most prevalent health condition affecting Gulf War veterans ([@bb0335]). GWI is characterized by diverse symptomology, affecting digestive (e.g., abdominal pain, chronic diarrhea), integumentary (e.g., idiopathic skin rashes), respiratory (e.g., chronic cough, dyspnea) and nervous systems (e.g., chronic headaches, cognitive impairment, neuropathic pain). Few studies have assessed the neural correlates of the cognitive symptoms experienced by GWI sufferers ([@bb0295], [@bb0425], [@bb0415], [@bb0420]). However, recent work suggests that cognitive deficits in GWI might arise from executive dysfunction caused by aberrant functioning of prefrontal neural systems ([@bb0190]).

Executive processes depend upon dorsolateral prefrontal cortex (DLPFC; e.g., [@bb0080], [@bb0085], [@bb0115], [@bb0190], [@bb0195], [@bb0360], [@bb0385], [@bb0375], [@bb0365], [@bb0370]). This area directs sensory and motor information and receives and integrates input from an array of specialized cortical structures ([@bb0080], [@bb0120], [@bb0115], [@bb0195], [@bb0290], [@bb0305], [@bb0310], [@bb0380], [@bb0370]). Indeed, blood-oxygen-level dependent (BOLD) activity changes in DLPFC are known to accompany executive cognitive deficits in GWI ([@bb0190]).

Prior research has established that connectivity between DLPFC and parietal regions, as well as other task-relevant regions, is predictive of individual differences in fundamental abilities ([@bb0235]), including cognitive slowing in healthy ([@bb0030], [@bb0380], [@bb0370]) and clinical populations ([@bb0195]). One study, for instance, found that slower performers showed increased DLPFC connectivity, and that significant variance in performance on the DSST could be explained by the degree of DLPFC connectivity ([@bb0380]). These results suggested that slower performers required greater DLPFC connectivity for executive control and monitoring processes. However, it remains unknown whether functional connectivity changes in DLPFC exist in GWI, and whether such changes might predict cognitive slowing in GWI.

In the present study, we assessed cognitive slowing and functional connectivity in GWI. Specifically, we used functional magnetic resonance imaging (fMRI) to assess the extent to which connectivity with DLPFC was altered during processing speed task performance in GWI relative to healthy-control veterans. We further assessed whether GWI-related changes in DLPFC functional connectivity could predict cognitive slowing in these patients.

2. Materials and Methods {#s0010}
========================

2.1. Participants {#s0015}
-----------------

Ninety-seven participants were selected by a three-stage sampling procedure from a nationally representative sample of Gulf War-era US military veterans, stratified by age, education, gender and wartime military rank ([@bb0150]). Sixty-six veterans (GWI patients) met the standardized factor case definition of the disease ([@bb0155]b; [@bb0215]), approximately equally representing the three syndrome variants defined by factor analysis: variant 1, impaired cognition; variant 2, confusion-ataxia; and variant 3, central neuropathic pain. All three variants were included to capture the full spectrum of the disorder ([@bb0155], [@bb0215]). All of the cases met the more inclusive CDC case definition ([@bb0105]), all but 2 met the Kansas case definition without comorbidity exclusions, and approximately half met the original Kansas case definition with comorbidities excluded ([@bb0405]). Thirty-one veterans (healthy controls) met none of the three case definitions. Complete task-performance and functional imaging data were available for 54 GWI patients and 29 healthy controls (*N* = 83); their characteristics are given in [Table 1](#t0005){ref-type="table"}. No participants had a diagnosable neurological condition, such as motor neuron disease, cerebrovascular disease, Parkinson's disease, Guillain-Barré syndrome, or traumatic brain injury.

All procedures were approved by institutional review boards from both the University of Texas at Dallas and the University of Texas Southwestern Medical Center. Participants provided informed consent prior to undergoing any procedure. All procedures were monitored by trained, certified MR technicians who screened participants for contraindications to MR imaging. Upon completion, all participants were compensated monetarily for their participation.

2.2. Behavioral measurement {#s0020}
---------------------------

Participants completed three runs of an fMRI-adapted digit-symbol substitution task (DSST; [@bb0380]). Each run lasted approximately 5 minutes and consisted of 75 trials. For each trial, a key containing 9 digit--symbol pairs was displayed in the upper half of the viewing screen. In the lower half, a single digit--symbol probe appeared simultaneously ([Fig. 1](#f0005){ref-type="fig"}). Participants were instructed to, as quickly and accurately as possible, press a right-thumb button if the probe-pair matched a pair in the key, and to press a left-thumb button if the probe-pair did not match one in the key. The probe-pair matched a pair in the key 50% of the time. Digit-symbol pairings in the key changed from trial to trial. Accuracy was calculated as the proportion of correct responses. Reaction time (RT) was calculated as the average time in ms it took a participant to respond correctly to a trial and was used to assess cognitive slowing.

2.3. Image acquisition and preprocessing {#s0025}
----------------------------------------

Imaging data were acquired using a Siemens 3 Tesla magnet with a 12-channel head coil. High-resolution anatomical, magnetization-prepared rapid acquisition of gradient echo (MPRAGE; [@bb0040]) scans were acquired using the following parameters: T1-weighted type, 1 × 1 × 1 mm³ voxel, 160 slices/ volume, sagittal plane, 3.31 ms echo time, 12° flip angle, 256 × 256 matrix, left-to-right acquisition, 281 s scan duration. Functional scans during the DSST were acquired using the following parameters: BOLD, gradient-echo signal, 2.97 × 2.97 × 3.5 mm³ voxel, 44 slices/volume, 159 volumes/run, transverse plane, 20 ms echo time, 2000 ms repetition time, 90° flip angle, 64 × 64 matrix, foot-to-head acquisition, 318 s per scan.

Analysis of Functional Neuroimages (AFNI; [@bb0075]) was used to process functional neuroimaging data. Data were de-spiked using AFNI's *3dDespike* program that applies a scaling factor to values larger than 2.5 standard deviations above the mean (spikes) such that they then fall between 2.5 and 4 standard deviations above the mean. This scaling was done to reduce undue effects of outlier signal measurements ([@bb0230]). Head motion was corrected by registering functional volumes to the first volume of the first run of the functional task using a six-parameter rigid-body transformation. The MPRAGE volume was aligned to the functional data. The MPRAGE was then transformed to Colin space ([@bb0185], [@bb0435]), where the transformation matrix was applied to warp the functional data into Colin space. Functional volumes within grey matter were then smoothed using a Gaussian kernel (full width at half maximum; FWHM = 3 mm). Signal contributions from white matter and participant motion were labeled as nuisance covariates and removed from further processing using regression analysis ([@bb0230]). A high-pass filter (0.015625 Hz) was applied to the data and linear and quadratic trends were removed. Volumes for each participant were visually inspected to ensure pre-processing programs operated as intended. Anatomical ROI masks were algorithmically delineated via AFNI's Talairach daemon ([@bb0075]) for each participant using Brodmann Area (BA) definitions for grey matter in left and right superior DLPFC corresponding to BA 9 (see [@bb0210]).

2.4. Image Analyses {#s0030}
-------------------

### 2.4.1. DLPFC ΔBOLD {#s0035}

Previous research has shown attenuated BOLD activity in DLPFC for GWI patients compared to healthy controls ([@bb0190]). The magnitude of linear dependence, as assessed using Pearson correlations, is contingent upon variability (e.g., [@bb0005]). Thus, when comparing two groups on measures of linear dependence, increases in BOLD time-series variability for one group compared to another could bias group differences in connectivity ([@bb0195]). Thus, prior to assessing group differences in connectivity within DLPFC, we ensured that GWI patients and healthy controls did not significantly differ in DLPFC variability. We thus computed ΔBOLD, that is, the standardized fluctuation of BOLD signal from the mean, within left and right DLPFC for GWI patients compared to healthy controls.

### 2.4.2. DLPFC connectivity {#s0040}

Using left and right BA 9 as seed regions, we performed voxelwise Pearson product-moment correlations between average BOLD signal time-series data in the seed regions and data in all other grey matter voxels. These correlations indicated how similarly time-series data in the seed region and in any other voxel in the brain varied together through time. Voxels with higher correlation coefficients are considered to be more connected than those with lower coefficients ([@bb0035], [@bb0030], [@bb0100], [@bb0195]). To normalize data distributions, a Fisher z-transformation ([@bb0095]) was applied to each Pearson correlation, yielding a z-connectivity score with left and right DLPFC, per voxel. Between-group connectivity differences were assessed using independent samples *t*-tests. Cluster-extent-based thresholding was used to correct for familywise error rate (FWER \< .05). The AFNI program *3dClustSim* estimated the probability of finding a noise-only cluster featuring faces-touching, contiguous voxels (*k*), on our specified grid space, with a smoothing kernel of 3 mm, and a *p*-value of .05 for each voxel within a cluster. At *k* ≥ 17, the probability of a noise-only cluster was *p* \< .05.

### 2.4.3. Definition of DLPFC hyper- and hypoconnectivity {#s0045}

We hypothesized that GWI-related hyperconnectivity with DLPFC was related to group differences in cognitive slowing. To test this hypothesis, from each participant we extracted the average connectivity z-score from all voxels in regions where GWI patients were significantly more connected with left and right DLPFC than healthy controls. We also extracted the average connectivity z-score in regions where GWI patients were significantly less connected with left and right DLPFC than healthy controls. This approach yielded two summary z-scores for each participant. One z-score represented the average connectivity with left and right DLPFC in regions where GWI patients showed significantly increased connectivity compared to healthy controls (i.e., the hyperconnectivity coefficient). The other z-score represented the average connectivity with left and right DLPFC in regions where GWI patients showed significantly reduced connectivity compared to healthy controls (i.e., the hypoconnectivity coefficient). We then assessed whether hyper- and hypoconnectivity coefficients could predict DSST RT.

2.5. Statistical Analysis {#s0050}
-------------------------

All within-group distributions were examined for outliers. Any observation greater than two standard deviations above or below the mean was removed from that distribution, as reflected by the degrees of freedom in any statistical analysis we performed. Additionally, we used multivariate ordinary least squares regression models in accordance with Baron and Kenny's protocol ([@bb0020]). Briefly, this method has four criteria for identifying an intervening variable ([Fig. 2](#f0010){ref-type="fig"}). First, the effect of X on Y (i.e., the direct effect) must be significant (path α in [Fig. 2](#f0010){ref-type="fig"}). Second, the effect of X on M must be significant (path β in [Fig. 2](#f0010){ref-type="fig"}). Third, the effect of M on Y (path τ in [Fig. 2](#f0010){ref-type="fig"}) controlling for X must be significant (path α\' in [Fig. 2](#f0010){ref-type="fig"}). Fourth, the effect of X on Y controlling for M must be non-significant or less than the effect of path α.

3. Results {#s0055}
==========

3.1. DSST Performance {#s0060}
---------------------

GWI patients and healthy controls did not significantly differ in DSST accuracy (*M*~GWI~ = 95.73 % \[*SEM* = 0.41 %\] vs. *M*~healthy~ = 97.03 % \[.56 %\]; *t*\[79\] = -1.87, *p* = .066). Because accuracy on the DSST was high (\> 95%) and did not differ between groups, all trials were used in neuroimaging analyses. GWI patients (*M*~GWI~ = 2223.60 ms \[44.11\]) were significantly slower to respond in the DSST compared to healthy controls (*M*~healthy~ = 1981.39 ms \[61.26\]; *t*\[80\] = 3.21, *p* = .002).

3.2. DLPFC ΔBOLD {#s0065}
----------------

GWI patients (*M*~GWI~ = 2.51 \[.06\]) did not significantly differ from healthy controls (*M*~healthy~ = 2.53 \[.08\]) in left DLPFC ΔBOLD (*t*\[77\] = -.186, *p* = .853). Similarly, no significant group differences were found between GWI patients (*M*~GWI~ = 2.48 \[.05\]) and healthy controls (*M*~healthy~ = 2.47 \[.07\]) in right DLPFC ΔBOLD (*t*\[78\] = .115, *p* = .909). [Fig. 3](#f0015){ref-type="fig"} depicts maps of BOLD signal during task across the entire brain for patients and controls.

3.3. DLPFC connectivity {#s0070}
-----------------------

Results of the connectivity analysis showed that GWI patients had both hyper- and hypoconnectivity with left and right DLPFC during DSST performance compared to healthy controls ([Table 2](#t0010){ref-type="table"}; [Fig. 4](#f0020){ref-type="fig"}).

3.4. Relationship between DLPFC connectivity and DSST RT {#s0075}
--------------------------------------------------------

DLPFC hyperconnectivity coefficients significantly predicted DSST RT (*β* = 2143.02, *r* = .296, *t*\[77\] = 2.72, *p* = .008). DLPFC hypoconnectivity coefficients did not significantly predict DSST RT (*β* = -1022.02, *r* = -.155, *t*\[78\] = -1.39, *p* = .169). Finding that (1) GWI patients had significantly longer RT than healthy controls, (2) GWI patients had significantly greater DLPFC hyperconnectivity than controls, and (3) the DLPFC hyperconnectivity coefficient significantly predicted DSST RT, we sought to test whether the relationship between the DLPFC hyperconnectivity coefficient and group differences in DSST RT suggested the presence of an intervening variable between the group variable and DSST RT (e.g., [@bb0020]). To test this, we utilized multiple regression predicting DSST RT from patients' group status and the hyperconnectivity coefficient. The overall model was significant (*F*\[2, 76\] = 5.73, *p =* .005, *R*² adj = .13). Examination of the individual factors showed that when controlling for DLPFC hyperconnectivity, patients' group status was no longer a significant predictor of DSST RT (*β* = -95.08, *t*\[76\] = -1.94, *p* = .056).

3.5. Parietal Connectivity and DSST RT {#s0080}
--------------------------------------

The finding that DLPFC hyperconnectivity was a significant intervening variable in the group-performance relationship suggests a central role for DLPFC in GWI-related cognitive slowing. Because activation-performance relationships have been observed in parietal cortex in previous work (e.g., [@bb0380], [@bb0370]), we performed similar analyses using left and right BA 7 (corresponding to superior parietal lobule and precuneus) as seed regions to assess the specificity of the DLPFC results. We performed the same steps as above for DLPFC (cluster thresholding was identical to DLPFC). The only difference between our parietal cortex connectivity analyses and those we performed for DLPFC was that in the parietal analyses, we excluded voxels within DLPFC because DLPFC-parietal connectivity had already been determined in the DLPFC seed analysis.

Consistent with DLPFC analyses, GWI patients had both hyper- and hypoconnectivity with left and right BA 7 during DSST performance compared to healthy controls ([Fig. 4](#f0020){ref-type="fig"}; see also [Supplementary Material](#ec0005){ref-type="supplementary-material"}). Inconsistent with DLPFC analyses, neither BA 7 hyperconnectivity coefficients (*β* = 272.43, *r* = .03, *t*\[78\] = .27, *p* = .786), nor hypoconnectivity coefficients (*β* = 267.75, *r* = .04, *t*\[79\] = .38, *p* = .707), significantly predicted DSST RT. Due to the absence of this relationship, there was no need to test whether parietal connectivity was an intervening variable in the relationship between group and DSST RT ([@bb0020]).

4. Discussion {#s0085}
=============

In this study, we compared processing speed and functional connectivity during DSST performance for GWI patients and healthy veteran controls. We assessed whether GWI-related changes in DLPFC functional connectivity were related to GWI patients' reductions in processing speed compared to controls. There were three principle results. First, RT of GWI patients during DSST performance was slower than that of controls, while accuracy did not differ between groups. Second, GWI patients showed both hyper- and hypoconnectivity between DLPFC and other regions throughout the brain compared to controls. Third, hyperconnectivity with DLPFC in these other regions predicted group differences in DSST RT. Hypoconnectivity was not predictive of these RT group differences. No such results were observed for connectivity with parietal cortex. Our results suggest that cognitive slowing in GWI results from inefficient connectivity within executive networks.

One possible explanation for these findings is a pathologically altered central cholinergic system. Epidemiologic studies have linked GWI to environmental exposure to chemicals that inhibit acetylcholinesterase (AChE), including organophosphate pesticides, pyridostigmine bromide, and sarin nerve gas ([@bb0065], [@bb0060], [@bb0130], [@bb0140], [@bb0160], [@bb0150], [@bb0145], [@bb0170], [@bb0180], [@bb0270], [@bb0430]). AChE is an enzyme necessary for degradation of the neurotransmitter acetylcholine. When AChE is inactivated, the resulting buildup of excess acetylcholine causes sustained excess stimulation, preventing neurons from returning to resting equilibrium and leading to excitotoxic damage. Other populations with documented poisoning by sarin nerve gas ([@bb0455]) or organophosphate pesticides ([@bb0090]) have chronic symptoms and neuropsychological abnormalities similar to those reported in GWI.

Executive cognitive function depends on the central cholinergic system, which modulates both processing speed and functional connectivity ([@bb0015], [@bb0010], [@bb0025], [@bb0165], [@bb0325], [@bb0345], [@bb0350], [@bb0355]; see [@bb0190]). Further, it is known that alterations to the cholinergic system can lead to changes in both functional connectivity and cognitive functioning ([@bb0345]). [@bb0345], for instance, assessed the effects of acute cholinergic augmentation on behavioral performance and functional connectivity. Participants performed a selective attention task during fMRI scanning immediately following administration of intravenous physostigmine (an acetylcholine enhancer) or saline placebo. Results showed that participants who received physostigmine were faster (i.e., showed decreased RT) than those who received a placebo, and showed reduced connectivity in prefrontal regions during the task relative to the placebo group. These results suggest that enhancement of the cholinergic system increases the efficiency of cognitive and neural processes. Recent studies have identified increased functional connectivity in early-moderate Alzheimer's disease ([@bb0225], [@bb0255], [@bb0395], [@bb0410]), also characterized by central cholinergic function loss ([@bb0280]) and slowed DSST RT ([@bb0260], [@bb0330]). Similarly, GWI patients are known to have abnormal cholinergic function ([@bb0160], [@bb0150], [@bb0270]) that could affect those DLPFC functions that control executive processes necessary for problem solving, reasoning, planning, and working memory (e.g., [@bb0045], [@bb0060], [@bb0110], [@bb0190], [@bb0195], [@bb0315], [@bb0320], [@bb0370], [@bb0400]).

An important question concerns the role that hyperconnectivity plays in GWI-related cognitive slowing. Under the assumption that damage to the central cholinergic system reduces neural signaling strength, possibly due to reduced ACh release at synapses ([@bb0125], [@bb0130]) or mitochondrial-related energetic impairments ([@bb0250], [@bb0245], [@bb0450]), additional neural cell assemblies might be recruited to maintain function. In the present results, these additional neural cell assemblies might be manifested as hyperconnectivity with DLPFC. Such added circuitry would be expected to slow RT (e.g., [@bb0380], [@bb0370]) as we observed here.

An alternative explanation might follow compensation-based models wherein recruitment of additional cognitive resources serves to minimize age- and disease-related performance deficits ([@bb0050], [@bb0300], [@bb0340]). Such compensation mechanisms are hypothesized to optimize performance through broader recruitment of available neural and cognitive resources. However, compensation-based models would have predicted greater connectivity associated with faster DSST performance, which we did not observe. Additional research is needed to understand relationships between BOLD signal, functional connectivity, and performance, particularly if they are to inform development of GWI treatment strategies.

Efficiency explanations conceptualize brain and behavior changes in terms of departures from ideal system function. Models of cognitive efficiency (e.g., [@bb0055], [@bb0200], [@bb0205], [@bb0285], [@bb0390], [@bb0440], [@bb0445]) have suggested that optimal performance results from simultaneously maximizing the speed of cognitive processes and minimizing expenditure of cognitive resources. In this view, cognitive performance depends upon information transmission across a network of processing nodes wherein information relay across fewer nodes allows more direct processing paths and thus faster information processing. Inefficiency results from increases in the number of connections required to traverse nodes and leads to increases in neural activity and slowing of information processing (cf. [@bb0175], [@bb0275], [@bb0365]).

5. Conclusion {#s0090}
=============

This study was the first to assess functional connectivity and processing speed in GWI patients. The slowing of reaction time and hyperconnectivity with DLPFC we observed in GWI patients suggest that their cognitive slowing is due to reductions in neural efficiency. Because DLPFC is central to executive cognitive functions, cognitive impairment experienced by GWI sufferers may be due to alterations to DLPFC connectivity evoked by ACh deficits. These findings thus support the conclusion that one of the most troublesome symptoms of GWI, cognitive slowing, is due to abnormal DLPFC functioning. That the study was performed in a sample of cases and controls drawn from a representative sample of Gulf War-era veterans strengthens the importance of this finding to the broader Gulf War veteran population. More generally, this finding establishes that GWI-related cognitive slowing is due to a pathological process, representing objective brain impairment.

The following is the supplementary data related to this article.Supplementary Table 1Anatomical regions showing hyper- or hypoconnectivity with BA 7.Supplementary Table 1.
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![A sample stimulus array from a single trial of the DSST.](gr1){#f0005}

![Baron & Kenny's protocol to identify an intervening variable. X is the independent variable, Y is the dependent variable, M is the intervening variable, α is the effect of X on Y, β is the effect of X on M, τ is the effect of M on Y, and α\' is the effect of X on Y controlling for M.](gr2){#f0010}

![Group-average activation maps depicting BOLD signal during task (as measured across all trials) for patients (above) and controls (below). Maps depict the top 10% of voxels for the whole brain, with a cluster threshold of k = 10. Circled in magenta are clusters located in DLPFC.](gr3){#f0015}

![Differences in connectivity on between veterans with Gulf War illness (N = 54) and matched controls (N = 29) on the DSST while undergoing fMRI. Results of seed-based connectivity analyses, using left and right BA 9 as seed regions. Voxels depict group differences in connectivity with the seed region in GWI patients relative to controls during DSST performance. Voxels appearing yellow and orange indicate hyperconnectivity; voxels appearing cyan and blue indicate hypoconnectivity.](gr4){#f0020}

###### 

Characteristics of the participants included in the analysis.

Table 1.

  Characteristic                                        Controls[a](#tf0005){ref-type="table-fn"} (N = 29)   GWI cases[a](#tf0005){ref-type="table-fn"} (N = 54)
  ----------------------------------------------------- ---------------------------------------------------- -----------------------------------------------------
  Age, mean (SD)                                        50.4 (7.8)                                           50.0 (8.0)
  Sex                                                                                                        
   Male                                                 23 (79)                                              43 (80)
   Female                                               6 (21)                                               11 (20)
  Handedness                                                                                                 
   Right                                                28 (97)                                              51 (94)
   Left                                                 1 ( 3)                                               3 ( 6)
  Education survey response, mean (SD)                  5.4 (1.6)                                            5.2 (1.8)
  Deployment to Kuwaiti Theater of Operations                                                                
   Deployed                                             15 (52)                                              55 (100)
   Non-deployed                                         14 (48)                                              0 ( 0)
  Wartime rank                                                                                               
   Officer                                              4 (14)                                               4 ( 7)
   Enlisted                                             25 (86)                                              50 (93)
  Syndrome variants of the Factor Case Definition                                                            
   Variant 1 (cognitive impairment)                     \--                                                  18 (33)
   Variant 2 (confusion/ataxia)                         \--                                                  22 (40)
   Variant 3 (neuropathic pain)                         \--                                                  15 (27)
  Met CDC criteria for multisymptom illness                                                                  
   Yes                                                  0 ( 0)                                               54 (100)
   No                                                   29 (100)                                             0 ( 0)
  Met Kansas criteria for multisymptom illness                                                               
   Yes                                                  0 ( 0)                                               30 (56)
   No                                                   29 (100)                                             24 (44)
  Met Kansas criteria with no co-morbidity exclusions                                                        
   Yes                                                  0 ( 0)                                               52 (96)
   No                                                   29 (100)                                             2 ( 4)

GWI patients met the Factor Case Definition of Gulf War illness, and controls did not meet it. Cells contain N (column %) unless otherwise specified in the row heading.

###### 

Anatomical regions showing hyper- or hypoconnectivity with left or right BA 9.

Table 2.

  Anatomical Region (BA)                *x*     *y*     *z*     Voxel count   *t*-value
  ------------------------------------- ------- ------- ------- ------------- -----------
  **Left BA 9**                                                               
  Right Declive                         \- 24   \- 69   \- 20   77            -3.101
  Right Medial Frontal Gyrus (10)       \- 03   \- 45   \- 09   52            3.692
  Right Culmen                          \- 21   \+ 48   \- 20   47            -3.716
  Right Cerebellar Tonsil               \- 15   \+ 51   \- 41   39            -3.150
  Right Tuber                           \- 30   \+ 77   \- 27   35            -3.853
  Right Cerebellar Tonsil               \- 45   \+ 51   \- 34   34            -2.841
  Left Insula (13)                      \+ 39   \+ 30   \+ 19   32            3.327
  Left Parahippocampal Gyrus (27)       \+ 15   \+ 33   \- 02   32            -4.505
  Left Inferior Parietal Lobule (40)    \+ 57   \+ 42   \+ 29   31            3.300
  Right Culmen                          \- 09   \+ 48   \- 16   31            -3.474
  Left Tuber                            \+ 36   \+ 80   \- 30   29            -3.471
  Right Inferior Semi-Lunar Lobule      \- 33   \+ 66   \- 37   27            -3.291
  Right Inferior Frontal Gyrus (47)     \- 30   \- 30   \- 06   23            3.125
  Left Superior Temporal Gyrus (38)     \+ 36   \+ 06   \- 16   19            4.190
  Right Fusiform Gyrus (37)             \- 45   \+ 45   \- 13   18            -4.273
  Right Middle Temporal Gyrus (21)      \- 57   \+ 06   \- 06   17            2.755
  Left Insula (47)                      \+ 33   \- 12   \+ 01   17            3.595
                                                                              
  **Right BA 9**                                                              
  Left Parahippocampal Gyrus (30)       \+ 15   \+ 36   \- 02   384           -4.621
  Right Cerebellar Tonsil               \- 09   \+ 39   \- 44   224           -3.748
  Left Pyramis                          \+ 09   \+ 80   \- 27   221           -4.230
  Right Superior Temporal Gyrus (42)    \- 65   \+ 18   \+ 08   53            4.003
  Right Tuber                           \- 30   \+ 77   \- 27   44            -3.152
  Right Middle Frontal Gyrus (9)        \- 42   \- 30   \+ 33   39            3.965
  Left Fusiform Gyrus (37)              \+ 36   \+ 63   \- 09   36            -3.426
  Right Postcentral Gyrus (3)           \- 51   \+ 15   \+ 40   34            3.037
  Right Superior Temporal Gyrus (22)    \- 57   \- 12   \- 06   30            3.713
  Left Inferior Semi-Lunar Lobule       \+ 21   \+ 63   \- 44   30            -3.174
  Right Inferior Frontal Gyrus (13)     \- 36   \- 21   \+ 08   28            3.484
  Left Medial Frontal Gyrus (10)        \+ 00   \- 50   \- 09   26            3.645
  Right Middle Frontal Gyrus (6)        \- 30   \- 06   \+ 54   23            2.626
  Left Inferior Frontal Gyrus (13)      \+ 33   \- 09   \- 16   22            3.590
  Right Middle Frontal Gyrus (45)       \- 45   \- 24   \+ 22   22            3.124
  Left Precentral Gyrus (3)             \+ 27   \+ 21   \+ 50   22            3.125
  Left Cerebellar Tonsil                \+ 12   \+ 51   \- 37   22            -3.753
  Right Fusiform Gyrus (37)             \- 48   \+ 45   \- 13   21            -3.629
  Left Middle Temporal Gyrus (39)       \+ 48   \+ 51   \+ 05   21            -2.866
  Right Middle Frontal Gyrus (46)       \- 54   \- 30   \+ 19   19            2.669
  Left Middle Temporal Gyrus (37)       \+ 48   \+ 57   \- 09   19            -3.537
  Left Declive (19)                     \+ 21   \+ 60   \- 13   18            -2.685
  Right Inferior Parietal Lobule (40)   \- 45   \+ 36   \+ 50   17            3.208

*x*, *y* and *z* are the Talaraich coordinates of the peak voxel in each cluster. T-values are independent-samples *t*-score of the peak voxel of each cluster. Significance was assessed at

*p =* .01, *k* ≥ 6, familywise error rate \< .05. Positive t-values indicate hyperconnectivity, and negative t-values indicate hypoconnectivity.

Anatomical regions are the Brodmann areas nearest the peak voxel (with 5 mm).
